Needham & Company LLC Reaffirms Buy Rating for Revolution Medicines (NASDAQ:RVMD)
Needham & Company LLC reissued their buy rating on shares of Revolution Medicines (NASDAQ:RVMD – Free Report) in a report published on Monday, Benzinga reports. Needham & Company LLC currently has a $61.00 price objective on the stock. A number of other analysts have also commented on the stock. Jefferies Financial Group assumed coverage on […]
10 Oct 08:49 · The Markets Daily